Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report?

Progyny (PGNY), a provider of fertility and family building benefits, is highlighted as a strong candidate to beat earnings estimates in its upcoming report on August 7, 2025. The company has a history of exceeding consensus, with an average earnings surprise of 10.09% over the last two quarters. This potential is underpinned by a positive Zacks Earnings ESP of +0.92% and a Zacks Rank #3 (Hold), a combination that historically predicts earnings beats nearly 70% of the time, signaling recent analyst optimism.

Analysis

Progyny (PGNY), a medical services firm specializing in fertility benefits, is presented as having a high probability of delivering a positive earnings surprise in its next report, scheduled for August 7, 2025. The basis for this outlook is a combination of a positive Zacks Earnings ESP (Expected Surprise Prediction) of +0.92% and a Zacks Rank #3 (Hold), a pairing that has historically yielded an earnings beat nearly 70% of the time. The positive ESP indicates that analysts have recently revised their earnings forecasts upward, suggesting growing optimism. The article cites a history of earnings beats, with an average surprise of 10.09% over the last two quarters. However, the underlying data presents a mixed picture: while the previous quarter saw a clear 13.51% beat with reported EPS of $0.42 against a $0.37 estimate, the most recent quarter's reported EPS of $0.45 was below the $0.48 consensus, a result the article still frames as a positive surprise of 6.67%. Despite this ambiguity in the most recent historical data, the primary forward-looking metrics highlighted in the report signal a bullish setup for the upcoming earnings announcement.

Key Decisions for Investors

• Given the positive +0.92% Earnings ESP and a Zacks Rank of #3, investors with a bullish thesis on PGNY may view this as a quantitative signal supporting potential upside ahead of the August 7th earnings release.
• Investors should closely scrutinize the upcoming earnings report for clarity on performance versus consensus, particularly given the conflicting data from the most recent quarter where reported EPS of $0.45 fell short of the $0.48 estimate.
• It is crucial to monitor analyst estimate revisions leading up to the report, as the positive ESP is a key pillar of the article's thesis and any change could alter the probability of an earnings beat.
• Consider the Zacks Rank #3 (Hold) as a signal of neutral underlying fundamentals, which tempers the more optimistic short-term earnings surprise prediction and suggests a balanced risk assessment is warranted.